Clinical Trial Update: PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF [Phase 1]

View source ↗

Summary

A Phase 1 PET imaging study of PIPE-791 in healthy volunteers and individuals with idiopathic pulmonary fibrosis and multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Multiple Sclerosis

Drugs mentioned

• PIPE-791

Snippet

Sponsor: Contineum Therapeutics | Conditions: Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED